- Home
- VCEL vs PSNY Comparison
VCEL vs PSNY Comparison
Compare VCEL & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | PSNY |
|---|---|---|
| Founded | 1989 | 2017 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCEL | PSNY |
|---|---|---|
| Price | $33.42 | $16.51 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $58.50 | $15.00 |
| AVG Volume (30 Days) | ★ 423.1K | 218.7K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.09 | $49.59 |
| Revenue Next Year | $17.96 | $31.71 |
| P/E Ratio | $105.00 | ★ N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $29.24 | $0.50 |
| 52 Week High | $49.10 | $23.28 |
Technical Indicators
Market Signals| Indicator | VCEL | PSNY |
|---|---|---|
| Relative Strength Index (RSI) | 37.46 | 44.87 |
| Support Level | $29.59 | $15.84 |
| Resistance Level | $38.48 | $19.86 |
| Average True Range (ATR) | 1.57 | 1.76 |
| MACD | -0.34 | -0.27 |
| Stochastic Oscillator | 10.53 | 17.60 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.